Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias
So while it is technically \u201coff-label\u201d to inject other parts of the face, we consider this to be a safe use of this product because it is so similar to a handful of other hyaluronic acid fillers which have been used for years to inject throughout the face
These products are not intended for human consumption, veterinary use, therapeutic use, or clinical application
For per-constituent identity, chemistry, and storage detail, see the BPC-157 and TB-500 product pages, and review lot documentation on the CoAs page
Product packaging and label may appear different than image shown.
If you have a mild deficiency, it may take two to three shots over several days or weeks before you begin feeling a difference